Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M61,985Revenue $M21,848Net Margin (%)11.8Z-Score3.7
Enterprise Value $M62,802EPS $1.6Operating Margin %12.0F-Score5
P/E(ttm))27.3Cash Flow Per Share $6.7Pre-tax Margin (%)11.5Higher ROA y-yN
Price/Book2.710-y EBITDA Growth Rate %-1.2Quick Ratio1.2Cash flow > EarningsY
Price/Sales3.05-y EBITDA Growth Rate %-22.9Current Ratio1.8Lower Leverage y-yN
Price/Cash Flow9.8y-y EBITDA Growth Rate %40.2ROA % (ttm)6.0Higher Current Ratio y-yN
Dividend Yield %1.7Insider Buy (3m)0ROE % (ttm)10.2Less Shares Outstanding y-yY
Payout Ratio %46.0Shares Outstanding M1,554ROI % (ttm)9.7Gross Margin Increase y-yN

Gurus Latest Trades with ABT

Number of guru portfolios checked: 56.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ABTGeorge Soros 2014-03-31 Add0.1%$35.85 - $40.12
($38.54)
$ 41.277%Add 25.97%1,222,181
ABTRay Dalio 2014-03-31 Buy 0.01%$35.85 - $40.12
($38.54)
$ 41.277%New holding, 17200 sh.17,200
ABTDaniel Loeb 2014-03-31 Sold Out -2.1%$35.85 - $40.12
($38.54)
$ 41.277%Sold Out0
ABTDaniel Loeb 2013-12-31 Buy 2.1%$33.01 - $38.71
($36.89)
$ 41.2712%New holding, 3250000 sh.3,250,000
ABTMario Gabelli 2013-12-31 Add0.02%$33.01 - $38.71
($36.89)
$ 41.2712%Add 110.21%197,183
ABTRay Dalio 2013-12-31 Sold Out -0.03%$33.01 - $38.71
($36.89)
$ 41.2712%Sold Out0
ABTPRIMECAP Management 2013-09-30 Add0.19%$32.93 - $36.88
($35.12)
$ 41.2718%Add 36.9%16,188,865
ABTRay Dalio 2013-09-30 Buy 0.03%$32.93 - $36.88
($35.12)
$ 41.2718%New holding, 118700 sh.118,700
ABTMason Hawkins 2013-09-30 Reduce-0.12%$32.93 - $36.88
($35.12)
$ 41.2718%Reduce -4.79%13,727,856
ABTJohn Hussman 2013-06-30 Sold Out -0.52%$34.88 - $38.56
($36.68)
$ 41.2712%Sold Out0
ABTVanguard Health Care Fund 2013-06-30 Reduce-0.24%$34.88 - $38.56
($36.68)
$ 41.2712%Reduce -18.79%7,591,400
ABTPRIMECAP Management 2013-03-31 Add0.23%$31.34 - $35.32
($33.84)
$ 41.2722%Add 58.55%11,683,747
ABTGeorge Soros 2013-03-31 Add0.23%$31.34 - $35.32
($33.84)
$ 41.2722%Add 93.84%1,140,752
ABTMario Gabelli 2013-03-31 Add0.01%$31.34 - $35.32
($33.84)
$ 41.2722%Add 40.97%84,215
ABTDaniel Loeb 2013-03-31 Sold Out -1.1%$31.34 - $35.32
($33.84)
$ 41.2722%Sold Out0
ABTJoel Greenblatt 2013-03-31 Sold Out -0.06%$31.34 - $35.32
($33.84)
$ 41.2722%Sold Out0
ABTMeridian Funds 2013-03-31 Sold Out -0.02%$31.34 - $35.32
($33.84)
$ 41.2722%Sold Out0
ABTMason Hawkins 2012-12-31 Add1.43%$14.4 - $16.51
($15.11)
$ 41.27173%Add 85.61%14,754,193
ABTDaniel Loeb 2012-12-31 Buy 1.1%$14.4 - $16.51
($15.11)
$ 41.27173%New holding, 1834000 sh.1,834,000
ABTGeorge Soros 2012-12-31 Add0.3%$14.4 - $16.51
($15.11)
$ 41.27173%Add 194.25%588,500
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ABT is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
ABT Ray Dalio 2014-03-3117,20000.01New Buy
ABT George Soros 2014-03-311,222,1810.080.47+25.97%
ABT PRIMECAP Management 2014-03-3117,087,0281.10.74+5.89%
ABT Mason Hawkins 2014-03-3113,747,3440.882.9+2.25%
ABT Dodge & Cox 2014-03-3136,95000+0.05%
ABT Vanguard Health Care Fund 2014-03-317,591,4000.490.82
ABT Mario Gabelli 2014-03-31168,4870.010.04-14.55%
ABT Daniel Loeb 2014-03-31000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


ABT: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Foltz Charles DSenior Vice President 2014-03-03Sell1,588$38.955.39view
Mason Heather LSenior Vice President 2014-03-03Sell2,196$38.955.39view
Blaser Brian JExecutive Vice President 2014-03-03Sell1,441$39.015.23view
ASHLEY RICHARD WExecutive Vice President 2014-03-03Sell2,098$395.26view
ALLEN HUBERT LExecutive Vice President 2014-03-03Sell1,543$39.035.18view
Funck Robert EVice President, Controller 2014-03-03Sell1,413$38.975.34view
FREYMAN THOMAS CExecutive Vice President 2014-03-03Sell2,984$39.14.99view
Contreras JaimeSenior Vice President 2014-03-03Sell8,081$39.374.27view
Warmuth Michael JExecutive Vice President 2014-03-03Sell16,484$39.015.23view
Doyle Katherine C.Senior Vice President 2014-03-03Sell6,639$39.015.23view

Press Releases about ABT :

Quarterly/Annual Reports about ABT:

News about ABT:

Articles On GuruFocus.com
6 Stocks Currently Trading Below Fair Value Jul 02 2014 
Why I Bought Baxter International Jun 19 2014 
Two Stocks On My Watch List For June 2014 May 29 2014 
Johnson & Johnson (JNJ) Dividend Stock Analysis May 29 2014 
What Drives St. Jude Medical to Be More Diversified? Apr 30 2014 
Different Opinions on Bio-Rad Laboratories Apr 03 2014 
Absolute and Relative Valuation Models Indicate the Same: Abbot Is a Buy Mar 31 2014 
We Are Confident About Baxter's Plan to Create Two Separate Health Care Companies Mar 28 2014 
Lountzis Asset Management Comments on Abbott Laboratories Mar 21 2014 
Abbott Capturing Incremental Market Share Mar 18 2014 

More From Our Partners
In Pursuit of Shire, AbbVie Eyes Lower Taxes in UK Jul 8 2014 - FOXBUSINESS

More From Other Websites
AbbVie Backtracks on Comments in Shire Bid Jul 09 2014
Drugmaker AbbVie raises bid for Shire by 11% Jul 08 2014
AbbVie raises its bid for Shire by about 11 pct Jul 08 2014
Global Exploration For Acquisitions Should Help Abbott Labs In The Future Jul 05 2014
The Zacks Analyst Blog Highlights: Abbott Laboratories, Medtronic, Johnson and Johnson, Becton,... Jul 03 2014
India Coronary Stent Market Would Continue to Grow in Double Digits and Abbott Vascular (NYSE:ABT)... Jul 01 2014
Study Offers Reassurance About Newer Drug-Eluting Stents Jul 01 2014
Your first trade for Monday Jun 27 2014
[video] FMHR Final Trade: EXPE, ABT & more Jun 27 2014
Abbott Is Undervalued With Significant Prospects In Vision Care Jun 26 2014
U.S. CDC recommends combo HIV test for faster detection of virus Jun 26 2014
Why I Am Not Always An Advocate Of Spin-Offs Or Breakups Jun 25 2014
Senators Say Walgreen Domicile Move Like 'Giving Up On America' Jun 25 2014
Abbott Hosts Conference Call for Second-Quarter Earnings Jun 25 2014
Abbott Laboratories: Recent Emerging Market Acquisitions Boost Growth Profile Jun 24 2014
Abbott Labs to Buy Russia-Based Veropharm Jun 24 2014
U.S. court refuses to undo gay rights ruling in pharma case Jun 24 2014
Abbott, Veropharm Deal Breaks Russian M&A Drought Jun 24 2014

Add Notes, Comments or Ask Questions

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide